Article

SCHOTT Opens Facility in China

SCHOTT began production of glass ampoules, vials, and cartridges at a new facility at the SCHOTT Xinkang headquarters in Zhejiang, China.

SCHOTT began production at a new plant for pharmaceutical packaging in China with an annual production capacity of two billion pieces, the company announced in a press release on Oct. 20, 2017. The plant is managed by the joint venture SCHOTT Xinkang and is located at joint venture headquarters in Jinyun, Zhejiang, China.

The plant highlights the company’s philosophy of keeping production sites close to the customers and markets. It will manufacture high-quality ampoules, vials, and cartridges made of premium glass tubing for the domestic pharma industry.

Source: SCHOTT

Newsletter

Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.

Related Videos
Shortcut from point A to point B | Image Credit: © Olivier Le Moal - stock.adobe.com
Behind the Headlines, Episode 21: Waters-BD Merger, Merck’s $10B Bet, and Biotech’s Investment Frontiers
© 2025 MJH Life Sciences

All rights reserved.